Alopecia secondary prevention

Jump to navigation Jump to search

Alopecia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Alopecia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Laser Therapy

Concealing Hair Loss

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alopecia secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alopecia secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alopecia secondary prevention

CDC on Alopecia secondary prevention

Alopecia secondary prevention in the news

Blogs on Alopecia secondary prevention

Directions to Hospitals Treating Alopecia

Risk calculators and risk factors for Alopecia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogechukwu Hannah Nnabude, MD

Overview

The aim of secondary prevention of alopecia is to stop progression and improve the chances of hair regrowth. This is achieved by treatment of underlying conditions, medications, and removal of any offending agents.

Secondary Prevention

  • Goal of treatment is to avoid future hair loss. Medications, if used, should be continued as stoppage will cause hair loss to resume.
  • Scarring hair loss prevents hair from going back.
  • Wigs and hair transplants
  • Anagen effluvium
  • Telogen effluvium
  • Treat underlying cause of alopecia
  • Hypothermia caps: This may help to prevent hair loss during some kinds of chemotherapy, specifically when tazanes or anthracyclines are used.[1] It should not be used when cancer has metastasized to the skin of the scalp or for lymphoma or leukemia.[2] There are generally only minor side effects from treatment.[3]
  • Acceptance: Some people, including celebrities, choose to accept their hair loss or completely shave their heads. Examples of celebrities who are bald include Michael Jordan, [4] Zinedine Zidane, [5] Dwayne Johnson,[6] Ben Kingsley,[7] and Jason Statham.[8]

References

  1. Grevelman, E.G.; Breed, W.P.M. (March 2005). "Prevention of chemotherapy-induced hair loss by scalp cooling". Annals of Oncology. 16 (3): 352–358. doi:10.1093/annonc/mdi088. PMID 15642703.
  2. Breed, Wim P. M. (1 January 2004). "What is wrong with the 30-year-old practice of scalp cooling for the prevention of chemotherapy-induced hair loss?". Supportive Care in Cancer. 12 (1): 3–5. doi:10.1007/s00520-003-0551-8. PMID 14615930.
  3. Komen, Manon M.C.; Smorenburg, Carolien H.; van den Hurk, Corina J.G.; Nortier, J.W.R. (Hans) (2011). "Hoofdhuidkoeling tegen alopecia door chemotherapie" [Scalp cooling for chemotherapy-induced alopecia] (PDF). Nederlands tijdschrift voor geneeskunde (in Dutch). 155 (45): A3768. PMID 22085565.
  4. Gaines, Cork (17 April 2020). "Michael Jordan once turned down a huge endorsement deal because he didn't like the product's name and another one because he was going bald". Business Insider.
  5. Will (5 March 2020). "The Bald Icons: Who is Zinedine Zidane?". The Bald Brothers. Retrieved 9 June 2020.[self-published source?]
  6. Bryant, Kenzie (3 April 2017). "Dwayne 'The Rock' Johnson Explains Why He's Bald". Vanity Fair.
  7. Steele, Francesca (19 April 2014). "Ferdinand Kingsley interview: 'Yeah, but mum's dad was totally bald too!'". Spectator. Retrieved 8 June 2020.
  8. Huynh, Mike (24 July 2019). "Jason Statham Is Showing Bald Men How To Look Stylishly Masculine". DMARGE. Retrieved 9 June 2020.

Template:WikiDoc Sources